Benitec Biopharma Inc.BNTCNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+17.7%
5Y CAGR+38.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+17.7%/yr
vs -2.8%/yr prior
5Y CAGR
+38.3%/yr
Recent deceleration
Acceleration
+20.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $622000.00 | +57.1% |
| 2025 | $396000.00 | +15.5% |
| 2024 | $343000.00 | -10.0% |
| 2023 | $381000.00 | +4133.3% |
| 2022 | $9000.00 | -92.7% |
| 2021 | $123000.00 | +166.5% |
| 2020 | $-185000.00 | -143.4% |
| 2019 | $426506.00 | +28.7% |
| 2018 | $331300.00 | +58.5% |
| 2017 | $209018.00 | - |